Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Provide scientific and validated data to help International Authorities to set susceptible to antibiotics cut-off points in bacteremia by Enterobacteriaceae
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Positive blood-culture to bacteremia by enterobacteria | Patients with positive blood-culture to bacteremia by enterobacteria |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Microbiological studies | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Correlation between the MIC of different antibiotics and the prognosis in patients with bacteremia. | Study the correlation between the minimum inhibitory concentration (MIC) of cefotaxime, ceftriaxone, cefepime, amoxicillin/clavulanic, piperacillin/tazobactam, ertapenem, imipenem, meropenem, ciprofloxacin and levofloxacin and the prognosis in patients with bacteremia by enterobacteria, with or without mechanisms of resistance | 36 months |
| Correlation between CLSI and EUCAST cut-off points, FC/FD cut-off points with clinical prognosis and of the microbiological response in patients with bacteremia. | Determine if the CLSI and EUCAST (European Committee on Antimicrobial Susceptibility Testing) sensitive clinical cut-off points, as well as the suggested by pharmacokinetic and pharmacodynamic studies (FC/FD) are properly independent predictors of clinical prognosis and of the microbiological response in patients with bacteremia | 36 months |
| Correlation between piperacillin/tazobactam serum concentrations and clinical prognosis | Evaluate if piperacillin/tazobactam serum concentrations are correlated with prognosis based on clinical sensitive cut-off points by CLSI and EUCAST | 36 months |
Not provided
Not provided
Inclusion Criteria:
>17 years old
Clinically significant bacteremia
Have received treatment fulfilling all this criteria:
Treated with an only active antibiotic with enterobacteria (association with vancomycin, linezolid, daptomycin, metronidazole or clindamycin) between: cefotaxime, ceftriaxone, ceftazidime, cefepime, amoxicillin/clavulanic, piperacillin/tazobactam, ertapenem, imipenem, meropenem, ciprofloxacin or levofloxacin
First antibiotic dose was administered during the first 12 hours after the time of sampling
The antibiotic dosage was at least the advised amount in the summary of product characteristics to patient renal function
The same antibiotic has been administered during at least 48 hours.
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with bacteremia by Enterobacteriaceae attended in participants Hospitals during the study period
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jesús Rodríguez-Baño | Hospital Universitario Virgen Macarena | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Universitario de Bellvitge | L'Hospitalet de Llobregat | Barcelona | Spain | |||
| Hospital Son Espases |
Not provided
| Label | URL |
|---|---|
| Related Info | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Whole blood
| Palma de Mallorca |
| Mallorca |
| Spain |
| Complejo Hospitalario Universitario A Coruña | A Coruña | Spain |
| Hospital Clínic | Barcelona | Spain |
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain |
| Hospital Universitario Vall d'Hebron | Barcelona | Spain |
| Hospital Universitario Reina Sofía | Córdoba | Spain |
| Hospital San Pedro | Logroño | Spain |
| Hospital Universitario La Paz | Madrid | Spain |
| Hospital Universitario Ramón y Cajal | Madrid | Spain |
| Hospital Marqués de Valdecilla | Santander | Spain |
| Hospital Universitario de Valme | Seville | Spain |
| Hospital Universitario Virgen de la Macarena | Seville | Spain |
| Hospital Universitario Virgen del Rocío | Seville | Spain |
| ID | Term |
|---|---|
| D016470 | Bacteremia |
| D004198 | Disease Susceptibility |
| ID | Term |
|---|---|
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D018805 | Sepsis |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D020969 | Disease Attributes |
Not provided
Not provided